Shimadzu introduces a novel automated artificial intelligence-driven HPLC method.
This whitepaper provides a detailed examination of Lonza’s holistic, data-driven approach to CCI, developed in collaboration with industry experts and applied across our global network for parenteral combination products.
AR/VR solution for visualizing multi-dimensional data in 3D. Explore sites on a 3D globe to detect trends and anomalies with ease.
Overcome matrix interferences in RNA–LNP endotoxin testing with LAL-based methods & recombinant factor C assays. Learn more in this whitepaper.
The use of AI technology in unifying clinical data across systems for making clinical trials more effective, safer and more efficient.
Learn how Medtronic processes and quantifies their xC/UV/MS data using the quantitation workflow in MS Workbook Suite.
A collaboration with Pfizer to create a tool to ensuring seamless method transfer between labs.
PTC Therapeutics accelerates drug discovery process by integrating physicochemical property predictions into their Dotmatics ELN.
Process chemists can increase their efficiency by accessing process, analytical, and chemical data from across their organization using Luminata.
Learn about available formats for analytical data standardization, limitations, and how to ensure data is usable by lab scientists and AI/ML.
NSF invites pharmaceutical professionals to tune in to its new groundbreaking podcast series “Compliance Unlocked” and join the conversation on critical industry issues.
Overcoming Challenges in Cell and Gene Therapy Containment.
NSF’s quality management maturity (QMM) assessment model: future-proofing quality and supporting supply chain robustness
Understanding and Applying the Updated FDA Guidance: Inspection of Injectable Products for Visible Particulates.
A guide on what to expect during a regulatory inspection and the differences in the approach taken by three of the main regulatory authorities and PIC/S.
This application note explores rapid microbial methods and balancing patient care, quality products, and safe shelf lives for unique formulations.
With a growing pipeline of biologics, increase in vaccine production, and small batch sizes targeting small patient populations, there’s increasing demand for advanced manufacturing tech.
Regulatory inspections can be challenging, but proper preparation turns them into opportunities for improvement and compliance demonstration.
Drug-device combination products offer advantages for patients but are complex and challenging to develop. Establish a holistic approach to DDCP development and assess and manage risk throughout the process.
Whitepaper - Optimising organisational culture and quality maturity is crucial in promoting consistent, reliable business processes and to minimise supply disruptions.
Whitepaper - Delivering Market Success for Pharma Partners from Concept to Patient
Selecting container closure components with confidence:A data-driven approach to Container Closure Integrity.
This application note explores how to determine the feasibility and the impact of the single temperature for environmental monitoring microorganisms.
Simplify your move from a vial to a prefilled syringe – lifecycle planning for containment and delivery of biologics drug products
How you can cut through complexity, gain speed and get your drug to the patient as soon as possible.
With complex processes and stringent regulatory requirements, the path to developing a combination product can be uncertain and challenging
Speed to market is a critical aspect of developing new pharmaceutical products, and scale-up – or scale-down – can play a key part in that process.
This whitepaper looks at benefits of measuring conductivity on-line, and calibration and temperature compensation criteria for USP compliance.
These longer synthetic pathways present challenges for process chemists hoping to achieve an efficient API manufacturing process.
Peak tracking in liquid chromatography (LC) method development can be challenging due to retention variations and co-elution. LabSolutions MD software with LCMS-2050 SQ-MS simplifies peak identification and automates method and sequence creation, enabling efficient development of reliable separation methods.
Specialised microbial testing is key in drug development to mitigate contamination risks, which threaten drug efficacy and patient safety. Bruker's MALDI Biotyper® at MPL, Austria, ensures accurate and robust testing, in a high-throughput workflow, delivering reproducible results.
Ambili Menon, Pharma Quality Control, bioMérieux Inc. addresses the task of microbiological testing for advanced therapeutic medicinal products.
Endotoxin testing continues to evolve alongside the industry’s need for more sustainable methods that reduce ecological impact. Nicola Reid, Associate Director of Endotoxin Products, Charles River Labs, reflects on these developments which are driven by the 3Rs (replacement, reduction and refinement).
Viral vector manufacturing presents many challenges related to HEK cell line development, fluid transfer and product viability in the cold chain.
This case study looks at how an online microbial analyzer provides real-time bioburden monitoring for rapid response to adverse water system events.
An EJPPS published study on Enzymatic Indicators in Vaporized Hydrogen Peroxide Decontamination Cycles: Application-related Research focusing on Fractional Kill Time (FKT) and Reverse Fractional Kill Time (RFKT) Studies
Identify molecular contamination concerns in the pharmaceutical workspace and determine the right filtration solution for dealing with these problems.